We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Researchers developed aggrecan-targeted, calcitriol-loaded nanoparticles (Agg-CLNP) that modulate immune cell activity to reduce rheumatoid arthritis onset and flare severity.
